CardioSet Medical
Pulmonary Edema Monitor
Company Overview
Snapshot
Founded in April 2016 by Prof. Michael Kleiner Shochat, CardioSet Medical operates with 1–10 employees. The company has raised $57,000 across one funding round. In April 2016, the Edema Guard Monitor demonstrated significant potential by reducing heart failure-related hospitalizations by more than half.
Business overview
CardioSet Medical is a Health Tech & Life Sciences company focused on developing medical devices for monitoring pulmonary congestion in heart failure patients. Its core product, the Edema Guard Monitor, is designed to detect small changes in lung fluid content, enabling early prediction of heart failure hospitalizations. The device provides immediate results, which are displayed directly and transmitted to cardiologists for timely medication adjustments. Operating within the Digital Healthcare and Medical Devices sectors, CardioSet Medical serves the healthcare industry globally, particularly targeting providers and chronic patients requiring remote monitoring.
Strategic signal
In April 2016, CardioSet Medical's Edema Guard Monitor demonstrated a significant reduction in heart failure-related hospitalizations, cutting them by more than half. This clinical validation signals a strong potential for improving patient outcomes and reducing healthcare burdens, indicating a promising trajectory for the company's non-invasive remote monitoring technology in the cardiology market.
Company Intelligence Q&A
- What is CardioSet Medical's primary product?
- CardioSet Medical's primary product is the Edema Guard Monitor, a medical device designed to monitor pulmonary congestion in patients with heart failure.
- When was CardioSet Medical founded?
- CardioSet Medical was founded in April 2016.
- Who is the founder of CardioSet Medical?
- Prof. Michael Kleiner Shochat is the founder of CardioSet Medical.
- What is the key benefit of the Edema Guard Monitor?
- The Edema Guard Monitor is sensitive to small changes in lung fluid content and can predict heart failure hospitalizations days before their occurrence, significantly reducing hospitalizations.
- What was a significant finding regarding the Edema Guard Monitor in April 2016?
- In April 2016, news reports indicated that the Edema Guard Monitor appeared to reduce heart failure-related hospitalizations by more than half, and significantly reduced hospitalizations and deaths compared with standard care.